Receptor isoform and ligand-specific modulation of dihydrotestosterone- induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens

Yuan Shan Zhu, Li Qun Cai, Ying Huang, Jason Fish, Lu Wang, Zhi Kai Zhang, Julianne L. Imperato-McGinley

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Androgens via the androgen receptor (AR) play crucial roles in prostate physiology and pathophysiology. These androgen actions can be either inhibited or potentiated by estrogens. The mechanisms of these seemingly opposing estrogen effects are unclear. We studied the effects of estrogens on the modulation of androgen induction of prostate specific antigen (PSA) gene expression and prostate tumor cell growth. Cotransfection analyses in CV-1, DU-145, and PC-3 cells showed that dihydrotestosterone (DHT)-induced PSA transcription activity was inhibited by 17β-estradiol, diethylstilbestrol, ICI182780, and 17α-estradiol, but not by tamoxifen via estrogen receptor α (ERα). In the presence of ERβ, 17β-estradiol and diethylstilbestrol had no significant effect, while 17α-estradiol inhibited and ICI182780 and tamoxifen potentiated DHT action. When both ERα and ERβ were present, all ER-ligands except tamoxifen inhibited DHT action. The inhibition of DHT action by 17β-estradiol via ERα was mainly dependent on the DNA binding domain, while the 17α-estradiol effect was mainly dependent on the ERα carboxyl terminus. Treatment with DHT in LAPC-4 prostate tumor cells that express a wild-type AR and both ERβ and ERα greatly increased the PSA gene expression and cell growth. These DHT effects were significantly attenuated by the addition of 17α-estradiol, 17β-estradiol, or cyproterone acetate in a dose-dependent manner. These results indicate that estrogens produce an ER-isoform- and ER-ligand-specific modulation of DHT induction of PSA gene expression and prostate tumor cell growth, providing a molecular basis for designing favorable agents for the prevention and control of prostate cancer.

Original languageEnglish (US)
Pages (from-to)500-508
Number of pages9
JournalJournal of Andrology
Volume26
Issue number4
DOIs
StatePublished - Jul 2005

Fingerprint

Dihydrotestosterone
Prostate-Specific Antigen
Estrogen Receptors
Prostate
Protein Isoforms
Estrogens
Ligands
Gene Expression
Estradiol
Growth
Neoplasms
Tamoxifen
Androgens
Diethylstilbestrol
Androgen Receptors
Cyproterone Acetate
Prostatic Neoplasms

Keywords

  • Androgen receptor
  • Androgens
  • Estrogen receptor

ASJC Scopus subject areas

  • Endocrinology

Cite this

Receptor isoform and ligand-specific modulation of dihydrotestosterone- induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens. / Zhu, Yuan Shan; Cai, Li Qun; Huang, Ying; Fish, Jason; Wang, Lu; Zhang, Zhi Kai; Imperato-McGinley, Julianne L.

In: Journal of Andrology, Vol. 26, No. 4, 07.2005, p. 500-508.

Research output: Contribution to journalArticle

Zhu, Yuan Shan ; Cai, Li Qun ; Huang, Ying ; Fish, Jason ; Wang, Lu ; Zhang, Zhi Kai ; Imperato-McGinley, Julianne L. / Receptor isoform and ligand-specific modulation of dihydrotestosterone- induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens. In: Journal of Andrology. 2005 ; Vol. 26, No. 4. pp. 500-508.
@article{3f129bd26c0d403192b6db963f7a63f1,
title = "Receptor isoform and ligand-specific modulation of dihydrotestosterone- induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens",
abstract = "Androgens via the androgen receptor (AR) play crucial roles in prostate physiology and pathophysiology. These androgen actions can be either inhibited or potentiated by estrogens. The mechanisms of these seemingly opposing estrogen effects are unclear. We studied the effects of estrogens on the modulation of androgen induction of prostate specific antigen (PSA) gene expression and prostate tumor cell growth. Cotransfection analyses in CV-1, DU-145, and PC-3 cells showed that dihydrotestosterone (DHT)-induced PSA transcription activity was inhibited by 17β-estradiol, diethylstilbestrol, ICI182780, and 17α-estradiol, but not by tamoxifen via estrogen receptor α (ERα). In the presence of ERβ, 17β-estradiol and diethylstilbestrol had no significant effect, while 17α-estradiol inhibited and ICI182780 and tamoxifen potentiated DHT action. When both ERα and ERβ were present, all ER-ligands except tamoxifen inhibited DHT action. The inhibition of DHT action by 17β-estradiol via ERα was mainly dependent on the DNA binding domain, while the 17α-estradiol effect was mainly dependent on the ERα carboxyl terminus. Treatment with DHT in LAPC-4 prostate tumor cells that express a wild-type AR and both ERβ and ERα greatly increased the PSA gene expression and cell growth. These DHT effects were significantly attenuated by the addition of 17α-estradiol, 17β-estradiol, or cyproterone acetate in a dose-dependent manner. These results indicate that estrogens produce an ER-isoform- and ER-ligand-specific modulation of DHT induction of PSA gene expression and prostate tumor cell growth, providing a molecular basis for designing favorable agents for the prevention and control of prostate cancer.",
keywords = "Androgen receptor, Androgens, Estrogen receptor",
author = "Zhu, {Yuan Shan} and Cai, {Li Qun} and Ying Huang and Jason Fish and Lu Wang and Zhang, {Zhi Kai} and Imperato-McGinley, {Julianne L.}",
year = "2005",
month = "7",
doi = "10.2164/jandrol.05002",
language = "English (US)",
volume = "26",
pages = "500--508",
journal = "Journal of Andrology",
issn = "0196-3635",
publisher = "American Society of Andrology Inc.",
number = "4",

}

TY - JOUR

T1 - Receptor isoform and ligand-specific modulation of dihydrotestosterone- induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens

AU - Zhu, Yuan Shan

AU - Cai, Li Qun

AU - Huang, Ying

AU - Fish, Jason

AU - Wang, Lu

AU - Zhang, Zhi Kai

AU - Imperato-McGinley, Julianne L.

PY - 2005/7

Y1 - 2005/7

N2 - Androgens via the androgen receptor (AR) play crucial roles in prostate physiology and pathophysiology. These androgen actions can be either inhibited or potentiated by estrogens. The mechanisms of these seemingly opposing estrogen effects are unclear. We studied the effects of estrogens on the modulation of androgen induction of prostate specific antigen (PSA) gene expression and prostate tumor cell growth. Cotransfection analyses in CV-1, DU-145, and PC-3 cells showed that dihydrotestosterone (DHT)-induced PSA transcription activity was inhibited by 17β-estradiol, diethylstilbestrol, ICI182780, and 17α-estradiol, but not by tamoxifen via estrogen receptor α (ERα). In the presence of ERβ, 17β-estradiol and diethylstilbestrol had no significant effect, while 17α-estradiol inhibited and ICI182780 and tamoxifen potentiated DHT action. When both ERα and ERβ were present, all ER-ligands except tamoxifen inhibited DHT action. The inhibition of DHT action by 17β-estradiol via ERα was mainly dependent on the DNA binding domain, while the 17α-estradiol effect was mainly dependent on the ERα carboxyl terminus. Treatment with DHT in LAPC-4 prostate tumor cells that express a wild-type AR and both ERβ and ERα greatly increased the PSA gene expression and cell growth. These DHT effects were significantly attenuated by the addition of 17α-estradiol, 17β-estradiol, or cyproterone acetate in a dose-dependent manner. These results indicate that estrogens produce an ER-isoform- and ER-ligand-specific modulation of DHT induction of PSA gene expression and prostate tumor cell growth, providing a molecular basis for designing favorable agents for the prevention and control of prostate cancer.

AB - Androgens via the androgen receptor (AR) play crucial roles in prostate physiology and pathophysiology. These androgen actions can be either inhibited or potentiated by estrogens. The mechanisms of these seemingly opposing estrogen effects are unclear. We studied the effects of estrogens on the modulation of androgen induction of prostate specific antigen (PSA) gene expression and prostate tumor cell growth. Cotransfection analyses in CV-1, DU-145, and PC-3 cells showed that dihydrotestosterone (DHT)-induced PSA transcription activity was inhibited by 17β-estradiol, diethylstilbestrol, ICI182780, and 17α-estradiol, but not by tamoxifen via estrogen receptor α (ERα). In the presence of ERβ, 17β-estradiol and diethylstilbestrol had no significant effect, while 17α-estradiol inhibited and ICI182780 and tamoxifen potentiated DHT action. When both ERα and ERβ were present, all ER-ligands except tamoxifen inhibited DHT action. The inhibition of DHT action by 17β-estradiol via ERα was mainly dependent on the DNA binding domain, while the 17α-estradiol effect was mainly dependent on the ERα carboxyl terminus. Treatment with DHT in LAPC-4 prostate tumor cells that express a wild-type AR and both ERβ and ERα greatly increased the PSA gene expression and cell growth. These DHT effects were significantly attenuated by the addition of 17α-estradiol, 17β-estradiol, or cyproterone acetate in a dose-dependent manner. These results indicate that estrogens produce an ER-isoform- and ER-ligand-specific modulation of DHT induction of PSA gene expression and prostate tumor cell growth, providing a molecular basis for designing favorable agents for the prevention and control of prostate cancer.

KW - Androgen receptor

KW - Androgens

KW - Estrogen receptor

UR - http://www.scopus.com/inward/record.url?scp=20544459160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20544459160&partnerID=8YFLogxK

U2 - 10.2164/jandrol.05002

DO - 10.2164/jandrol.05002

M3 - Article

VL - 26

SP - 500

EP - 508

JO - Journal of Andrology

JF - Journal of Andrology

SN - 0196-3635

IS - 4

ER -